ArticleEuropean radiology experimental2026
Cerebrovascular CTA radiomics for objective collateral grading in acute ischemic stroke.
Article in European radiology experimental, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectiveCollateral circulation is a key determinant of functional outcome after large vessel occlusion (LVO) and informs thrombectomy decisions. However, collateral grading is rater-dependent and error-prone. We developed an automated cerebrovascular radiomics pipeline to establish objective collateral scoring on computed tomography angiography (CTA). MATERIALS AND
methodsWe retrospectively analyzed admission CTAs from 343 LVO patients in the MR CLEAN trial, split into training/validation (n = 274) and testing (n = 69) sets. Vessel regions of interest were segmented using nnU-Net models trained on 40 arterial tree CTAs and 125 multiclass circle of Willis (CoW) cases. Radiomics features were extracted from vascular regions. Predictive features were identified, and a random forest classifier was trained to distinguish sufficient (> 50%) from insufficient (≤ 50%) collateral status according to the Tan score system. Performance was compared to the atlas-based middle cerebral artery (MCA) mask model and validated on an external cohort of 140 acute LVO patients.
resultsSegmentation models accurately annotated cerebral arteries (95th percentile Hausdorff distance 4.49, Dice similarity coefficient 0.83) and CoW segments (2.27 and 0.81, respectively). After feature selection, 6 top features were identified for vessel-tree radiomics, 98 for MCA mask-based radiomics, and 32 for a combined vessel-tree/CoW model. Vessel-tree outperformed MCA mask model on both internal (area under the receiver operating characteristic curve (AUROC): 0.88 versus 0.82) and external (AUROC: 0.83 versus 0.66) test sets. Adding CoW features further improved performance, achieving 0.87 AUROC.
conclusionWe presented a fully automated generalizable CTA radiomics approach for objective collateral scoring in acute LVO. RELEVANCE STATEMENT: This study introduces a fully automated CTA cerebrovascular radiomics pipeline that objectively assesses collateral status in patients with acute ischemic stroke. Combining vessel-tree and circle of Willis features improved collateral score prediction accuracy and generalizability, supporting more reliable, data-driven decision-making in acute large vessel occlusion management. KEY POINTS: Collateral circulation status informs prognosis and guides treatment in acute stroke, but grading is rater-dependent; our pipeline standardizes collateral assessment. We propose a CTA radiomics approach, trained and validated on multicenter data, externally tested on an independent cohort, demonstrating high effectiveness and generalizability. Automated and reliable collateral scoring has the potential to reduce inter-rater variability, improve workflow efficiency, and support individualized treatment decisions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.